Concepedia

Luke A. Wittenburg

LA

25

Publications

818

Citations

16

H-Index

2010

Active since

Affiliations

Colorado State University(Current)

University of California, Davis

University of Colorado Denver

University of Colorado Cancer Center

Washington State University

Luke A. Wittenburg is an author at Colorado State University specializing in medicine, cancer research, and pharmacology.

ORCID

Top concepts

Publications per year

2010–2023

25

Publications

25

Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma

Rebecca Barnard, Luke A. Wittenburg, Ravi K. Amaravadi et al. · Autophagy · 2014 · 162 citations · Full text

, , +21

Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs.

Lisa R. Bartner, Stephanie McGrath, Sangeeta Rao et al. · PubMed · 2018 · 129 citations · Full text

The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin

Luke A. Wittenburg, Liam Bisson, Barbara Rose et al. · Cancer Chemotherapy and Pharmacology · 2010 · 64 citations · Full text

, , +8

An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats

Sarah Cook, Luke A. Wittenburg, Victoria C. Yan et al. · Viruses · 2022 · 37 citations · Full text

Phase I Pharmacokinetic and Pharmacodynamic Evaluation of Combined Valproic Acid/Doxorubicin Treatment in Dogs with Spontaneous Cancer

Luke A. Wittenburg, Daniel L. Gustafson, Douglas H. Thamm · Clinical Cancer Research · 2010 · 34 citations · Full text

Rows per page

1–5 of 25